The Impact of Prosecution Length on Patent Litigation Outcomes
Why It Matters
Understanding that more prosecution steps can signal higher invalidation risk helps companies better assess patent strength and informs policy debates on USPTO examiner incentives.
Key Takeaways
- •More office actions slightly increase patent invalidity likelihood.
- •Number of office actions serves as proxy for examination thoroughness.
- •Crowded prior art fields drive higher office action counts and invalidity.
- •Examiner workload incentives may reduce scrutiny on later office actions.
- •Post‑2010 point‑system changes could affect patent validity outcomes.
Summary
The Berkeley Center for Law and Technology webcast featured Baker Botts partner Matt Avery presenting a Harvard Tech Law Journal paper that examined how the length of patent prosecution—measured by the number of office actions before allowance—correlates with litigation outcomes. Using a dataset of roughly 89,000 litigated patents spanning 2000‑2021, the study isolated about 10,000 cases with definitive court or PTAB results and tested hypotheses that more office actions would yield narrower claims, lower invalidity rates, and reduced infringement risk.
Contrary to the authors’ gut feeling, the empirical results showed a modest but consistent rise in invalidity probability as office‑action counts increased—from roughly 35% to 40% across five actions. The panelists interpreted this as evidence that a higher number of actions often reflects a crowded prior‑art landscape rather than rigorous examination. In such dense fields, examiners issue additional actions to address abundant references, yet the eventual allowance may still leave vulnerable claim language that later courts invalidate.
Daisy Yau highlighted the link between office‑action volume and prior‑art density, suggesting future work should track citation diversity to confirm the pattern. Keith Jurek added that diminishing examiner time incentives—especially after the 2010 point‑system revision—may allow new matter or insufficient 112/101 analysis to slip through, creating exploitable gaps for litigants. Both panelists agreed that the findings challenge the notion of “junk patents” and point to systemic incentives shaping patent quality.
For practitioners, the study signals that office‑action count is an imperfect quality metric; firms should prioritize deep prior‑art mapping and monitor examiner workload trends when managing portfolios. Policymakers may need to revisit examiner incentive structures to ensure thoroughness throughout prosecution, potentially reducing downstream invalidity and litigation costs.
Comments
Want to join the conversation?
Loading comments...